HBK INVESTMENTS L P
Institutional investor · Portfolio as of Q2 2022
Top Holdings521 positions
SPDR S&P 500 ETF TRUST | 20.9M | $7.9B | 44.1% | — | — | — | New — |
SPDR S&P 500 ETF TRUST | 10.9M | $4.1B | 23.1% | — | — | — | New — |
ISHARES TR | 2.5M | $424.6M | 2.4% | — | — | — | New — |
| 3.8M | $235.4M | 1.3% | — | — | 1 qtr | New 70 | |
CMC MATERIALS INC | 1.3M | $224.3M | 1.3% | — | — | 1 qtr | New 70 |
AMERICAN CAMPUS COMMUNITIES | 3.3M | $209.5M | 1.2% | — | — | 1 qtr | New 70 |
COHERENT INC | 700,000 | $186.5M | 1.0% | $58.03 | +438.72% | 2 qtrssince 2022-Q1 | Increased 78 |
WELBILT INC | 5.8M | $136.9M | 0.8% | — | — | 3 qtrssince 2021-Q4 | Increased 59 |
ACTIVISION BLIZZARD INC | 1.7M | $128.5M | 0.7% | — | — | 2 qtrssince 2022-Q1 | Decreased 0 |
BIOHAVEN PHARMACEUTICAL HOLD | 825,000 | $120.2M | 0.7% | — | — | 1 qtr | New 59 |
PNM RESOURCES INC | 2.1M | $102.2M | 0.6% | $41.76 | -0.37% | 6 qtrssince 2021-Q1 | Decreased 0 |
VONAGE HOLDINGS CORP | 5.1M | $95.7M | 0.5% | — | — | 3 qtrssince 2021-Q4 | Increased 42 |
MANDIANT INC | 3.7M | $81M | 0.5% | — | — | 2 qtrssince 2022-Q1 | Increased 50 |
BERKSHIRE HATHAWAY INC-CL B | 286,800 | $78.3M | 0.4% | — | — | — | New — |
| 75.8M | $74.7M | 0.4% | — | — | 1 qtr | New 49 | |
UTILITIES SELECT SECTOR SPDR | 1M | $70.1M | 0.4% | — | — | — | New — |
ZENDESK INC | 922,305 | $68.3M | 0.4% | — | — | 1 qtr | New 49 |
AIRBNB INC | 763,400 | $68M | 0.4% | — | — | — | New — |
AIRBNB INC | 761,400 | $67.8M | 0.4% | — | — | — | New — |
TWITTER INC | 1.8M | $66.3M | 0.4% | — | — | 1 qtr | New 49 |
HBK INVESTMENTS L P manages $17.9B across 521 positions as of Q2 2022. Top holdings: SPY puts (44.1%), SPY calls (23.1%), IWM puts (2.4%). Fund DNA: Momentum Trader. HoldingsIntel Score: 2/5.0.
Active quarter - 54 new positions, 215 exits, 117 increased. Top move: COHR (INCREASED, conviction 78). Portfolio: $17.9B across 521 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR